Clinical Trial Update: Early Assessment of the Response to Neo-adjuvant Chemotherapy in Breast Cancer Patients With FDG-PET [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial in breast cancer evaluates early response to neoadjuvant chemotherapy using FDG-PET imaging; the study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Centre Oscar Lambret | Conditions: Breast Cancer | Phase 4 | Status: COMPLETED